Cargando…
Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy
SIMPLE SUMMARY: Glioblastoma (GBM) is the main malignant brain tumor in adults. It has a poor survival rate and a short disease-free life in spite of all available treatments. The science of cancer immunotherapy is constantly adapting to address the particular needs and problems of a wide range of c...
Autores principales: | Fekrirad, Zahra, Barzegar Behrooz, Amir, Ghaemi, Shokoofeh, Khosrojerdi, Arezou, Zarepour, Atefeh, Zarrabi, Ali, Arefian, Ehsan, Ghavami, Saeid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367505/ https://www.ncbi.nlm.nih.gov/pubmed/35954362 http://dx.doi.org/10.3390/cancers14153698 |
Ejemplares similares
-
Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque
por: Naderi Sohi, Alireza, et al.
Publicado: (2021) -
Autophagy and Biomaterials: A Brief Overview of the Impact of Autophagy in Biomaterial Applications
por: Pirmoradi, Leila, et al.
Publicado: (2023) -
Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
por: Barzegar Behrooz, Amir, et al.
Publicado: (2022) -
MicroRNA-129 Inhibits Glioma Cell Growth by Targeting CDK4, CDK6, and MDM2
por: Moradimotlagh, Atieh, et al.
Publicado: (2019) -
Spions as nano-theranostics agents
por: Zarepour, Atefeh, et al.
Publicado: (2017)